ResearcherCentre Léon BérardNo recent work listed
Pauline Rochefort
Matched on ORCID iD 0000-0003-4734-6896; OpenAlex author ID A5001003272. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2019: 2 papers · 2020: none · 2021: none · 2022: 1 paper
Papers 3
- A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3. Co-author DOI 10.3390/jpm12040623↗
- Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis. Co-author DOI 10.1634/theoncologist.2018-0786↗
- FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study. Co-author DOI 10.3747/co.26.4903↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christelle de la Fouchardière · 3 shared papers, 2019–2022 · strength 0.33
- Paper A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3. DOI 10.3390/jpm12040623↗
- Paper Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis. DOI 10.1634/theoncologist.2018-0786↗
- Paper FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study. DOI 10.3747/co.26.4903↗
- Matthieu Sarabi · 3 shared papers, 2019–2022 · strength 0.33
- Paper A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3. DOI 10.3390/jpm12040623↗
- Paper Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis. DOI 10.1634/theoncologist.2018-0786↗
- Paper FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study. DOI 10.3747/co.26.4903↗
- Sophie Bachy · 1 shared paper, 2022 · strength 0.12
- Anà Hennino · 1 shared paper, 2022 · strength 0.12
- Elise Bonnet · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.